Dr. Gapany's primary research focus is identifying prognostic markers in head and neck tumors.
Gleich LL. Gluckman JL. Nemunaitis J. Suen JY. Hanna E. Wolf GT. Coltrera MD. Villaret DB. Wagman L. Castro D. Gapany M. Carroll W. Gillespie D. Selk LM. Clinical experience with HLA-B7 plasmid DNA/lipid complex in advanced squamous cell carcinoma of the head and neck. Archives of Otolaryngology -- Head & Neck Surgery. 127(7):775-9, 2001 Jul. Imola MJ.
Gapany M. Grund F. Djalilian H. Fehling S. Adams G. Technetium 99m single positron emission computed tomography scanning for assessing mandible invasion in oral cavity cancer. Laryngoscope. 111(3):373-81, 2001 Mar.
Bier-Lansing CM. Hom DB. Gapany M. Manivel JC. Duvall AJ 3rd. Microcystic adnexal carcinoma: management options based on long-term follow-up. Laryngoscope. 105(11):1197-201, 1995 Nov.
Gapany M. Dawson DE. Schriever C. Burgess R. Gipple JR. Riggs CE Jr. Tumor necrosis factor and cytotoxic agents. Effect on squamous carcinoma lines. Archives of Otolaryngology -- Head & Neck Surgery. 116(4):436-9, 1990 Apr.
Mukherji SK. Gapany M. Neelon B. McCartney W. Evaluation of 201T1 SPECT for predicting early treatment response in patients with squamous cell carcinoma of the extracranial head and neck treated with nonsurgical organ preservation therapy: initial results. Journal of Computer Assisted Tomography. 24(1):146-51, 2000 Jan-Feb.
Hebrew University, Hadassah School of Medicine
University of Iowa
University of Cincinnati (Head and Neck Oncologic Surgery)
720 Washington SE, #200
Minneapolis, MN 55414
612.672.7422 - Adults
888.KIDS.UMN - Pediatrics